undergoing treatment for acute lymphoblastic leukemia (ALL) and to compare the results
with those from age-matched healthy children. We used the MTI Actigraph accelerometer to
determine PA (during a 1 week period) in children (n= 7; age= 4–7 y) undergoing
maintenance treatment for ALL and in age-matched controls (n= 7). The number of children
accumulating at least 60 min of moderate-to-vigorous physical activity (MVPA) for 5 or more …